Literature DB >> 9097011

Trends in mammography and Pap smear utilization in Canada.

J Snider1, J Beauvais, I Levy, P Villeneuve, J Pennock.   

Abstract

We have examined trends in the utilization of two preventive health procedures for women in Canada based on our analysis of the 1994 National Population Health Survey (NPHS) and comparisons with two previous large population health surveys. The NPHS provides evidence that Canadian women's use of mammography has continued to increase between 1990 and 1994, while use of Pap smears has remained steady. Increases in mammographic utilization are seen for all age groups and in all provinces of Canada. Women who are less than the recommended age of 50-69 years for screening mammography access these services in considerable numbers. Large proportions of women aged 18-24 and 65 or over have never had a Pap smear, and recency of Pap smear is associated with age. Income adequacy and educational attainment are still strong predictors of which women utilize Pap smears and mammograms. We conclude that the NPHS is sufficiently broad-based to be used in a surveillance program to track Pap smear and mammography utilization.

Entities:  

Mesh:

Year:  1996        PMID: 9097011

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  14 in total

1.  Delivering equitable care: comparing preventive services in Manitoba.

Authors:  Sumit Gupta; Leslie L Roos; Randy Walld; Dawn Traverse; Matthew Dahl
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

2.  Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996.

Authors:  Edward Ng; Russell Wilkins; Michael Fung Kee Fung; Jean-Marie Berthelot
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

3.  Implementation of electronic medical records: effect on the provision of preventive services in a pay-for-performance environment.

Authors:  Michelle Greiver; Jan Barnsley; Richard H Glazier; Rahim Moineddin; Bart J Harvey
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

4.  Cancer preventive screening: a cross-border comparison of United States and Canadian Chinese women.

Authors:  Shin-Ping Tu; Sara L Jackson; Yutaka Yasui; Michéle Deschamps; T Gregory Hislop; Vicky M Taylor
Journal:  Prev Med       Date:  2005-07       Impact factor: 4.018

5.  Cervical cancer: screening hard-to-reach groups.

Authors:  E Grunfeld
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

6.  Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.

Authors:  Jeannie Haggerty; Fred Tudiver; Judith Belle Brown; Carol Herbert; Antonio Ciampi; Remi Guibert
Journal:  Can Fam Physician       Date:  2005-12       Impact factor: 3.275

7.  Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women.

Authors:  Gina Ogilvie; Mel Krajden; Juanita Maginley; Judy Isaac-Renton; Greg Hislop; Ruth Elwood-Martin; Chris Sherlock; Darlene Taylor; Michael Rekart
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

8.  Determining use of preventive health care in Ontario: comparison of rates of 3 maneuvers in administrative and survey data.

Authors:  Li Wang; X Nie Jason; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

9.  Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project.

Authors:  Electra D Paskett; John M McLaughlin; Paul L Reiter; Amy M Lehman; Dale A Rhoda; Mira L Katz; Erinn M Hade; Douglas M Post; Mack T Ruffin
Journal:  Prev Med       Date:  2009-09-08       Impact factor: 4.018

10.  Factors influencing mammography participation in Canada: an integrative review of the literature.

Authors:  K Hanson; P Montgomery; D Bakker; M Conlon
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.